Market Overview

Pandora Inks Licensing Agreements With ASCAP And BMI, Withdraws Prior Appeal

Share:
Pandora Inks Licensing Agreements With ASCAP And BMI, Withdraws Prior Appeal

Shares of Pandora Media Inc (NYSE: P) were trading higher by 1.76 percent at $14.47 Tuesday morning after the company announced it signed a licensing agreement with ASCAP and BMI.

Pandora agreed to two separate multi-year licensing agreements with ASCAP and BMI for their combined music portfolio, which consist of more than 20 million musical works.

See Also: Wall Street's Take On The Pandora Copyright Ruling

Pandora also announced that it will withdraw a May 2015 appeal related to a BMI rate court decision. A federal judge concluded that BMI's royalty was "reasonable, and indeed at the low wend of the range of fees of recent licences" and Pandora should pay BMI a higher royalty rate.

"At Pandora we are delivering on our commitment to ensure that music thrives," said Brian McAndrews, chief executive officer of Pandora. "These collaborative efforts with the leading Performance Rights Organizations, as well as our recent direct deals with several music publishers demonstrate our progress in working together to grow the music ecosystem."

Posted-In: ASCAP BMI Brian McAndrews Pandora Streaming musicNews Legal Tech Best of Benzinga

 

Related Articles (P)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Big Bank Q4 Outlook: KBW Slashes Estimates on Goldman, Morgan Stanley, State Street

Express Scripts Trading Higher After Reaffirming 2015 Guidance, Initial Look At 2016